582 Companies
Houston-based pharmaceutical company Moleculin Biotech, Inc. is making strides in the development of drug candidates for the treatment of cancers and viruses. Its Annamycin drug candidate is curren...
Moleculin Biotech, Inc. Annual Report 2023Durham-based medical dermatology company, Novan, Inc., is actively focused on developing and commercializing therapeutic products to combat various skin diseases. With a range of clinical stage der...
Novan Annual Report 2021Axsome Therapeutics Inc., a US-based biopharmaceutical firm, is dedicated to the creation of innovative treatments for central nervous system (CNS) disorders. The company has a strong commercial pr...
Axsome Therapeutics Annual Report 2023Development-stage biopharmaceutical company Verastem, Inc. is at the forefront of cancer treatment drug development and commercialization. Among its promising products in development is VS-6766, a ...
Verastem Oncology Annual Report 2023BlackRock Inc. has recently launched their BlackRock Floating Rate Income Trust, which operates as a close-ended fixed income mutual fund. The fund, which is administered by BlackRock Advisors, LLC...
Bio-Gene Technology Limited Annual Report 2023SkinBioTherapeutics is a promising life science company that strives to enhance skin health through its unique platform technology, SkinBiotix®. This proprietary technology is the result of extensi...
SkinBioTherapeutics Annual Report 2023Sorrento Therapeutics is making strides in its development of new treatments for cancer, inflammation, and autoimmune diseases. The California-based biopharmaceutical company is focused on antibodi...
Sorrento Therapeutics Annual Report 2021Cabaletta Bio, a biotech startup headquartered in Philadelphia, is making waves with their cutting-edge work on engineered T cell therapies to treat B cell-mediated autoimmune diseases. Currently, ...
Cabaletta Bio, Inc. Annual Report 2023Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is a leading clinical stage immuno-oncology company that is pioneering the development of innovative therapies to treat cancer. The company's research i...
Trillium Therapeutics Inc. Annual Report 2019Kadmon is a biotech firm dedicated to creating lifesaving therapies for patients with unmet medical needs. The company is developing a range of innovative products, with a focus on inflammatory and...
Kadmon Holdings, Inc. Annual Report 2019Doylestown, Pennsylvania-based Aprea Therapeutics, Inc. is making strides in its mission to create and distribute cancer therapeutics that utilize synthetic lethality. The biopharmaceutical company...
Aprea Therapeutics, Inc. Annual Report 2023Clinical-stage immuno-oncology company, Surface Oncology, Inc. is making waves in the US cancer drug development scene with its range of innovative cancer therapies. The company's portfolio of anti...
Surface Oncology Annual Report 2021Bedford-based Homology Medicines, Inc. is making strides in transforming the lives of individuals affected by rare genetic diseases. By utilizing its proprietary platform, the genetic medicines com...
Homology Medicines Annual Report 2021CASI Pharmaceuticals, Inc., a biopharmaceutical company with operations in China, the United States, and globally, focuses on developing and selling pharmaceutical products and therapeutics for var...
CASI Pharmaceuticals Inc Annual Report 2021Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, is on a mission to develop and market breakthrough product candidates for the treatment of central nervous system diseases. ...
Minerva Neurosciences Annual Report 2023